Wall Street sets Northrop Grumman stock price for next 12 months

Northrop Grumman (NOC) shares rallied nearly 4% to $497.70, reflecting broader defense sector growth, following the deployment of its B-2 bombers in a recent Middle East strike. Analyst sentiment is largely bullish, with 10 of 15 analysts rating it a 'Buy' and an average 12-month price target of $541.36, representing an 8.8% upside. The stock's outlook is further supported by speculation of expanded Pentagon procurement and anticipation of its Q2 2025 earnings report on July 22.

Analysis

Northrop Grumman (NOC) has experienced a significant stock price appreciation, rising nearly 4% to $497.70, directly linked to the operational deployment of its B-2 Spirit bombers in a recent Middle East conflict. This event highlights the strategic value of its defense platforms in the current geopolitical landscape and has fueled speculation about expanded Pentagon procurement. The positive market reaction is strongly supported by analyst sentiment, with 10 of 15 analysts issuing a "Buy" rating and no "Sell" ratings. The consensus 12-month price target of $541.36 suggests a further 8.8% upside potential. Notably, Goldman Sachs upgraded its rating from "Sell" to "Neutral" in April and sharply raised its price target to $521, indicating a re-evaluation of the company's prospects even before the latest conflict escalation. With the stock already up 6.34% year-to-date, the upcoming Q2 2025 earnings report on July 22 serves as a critical near-term catalyst, where investors will seek confirmation of improved financial performance and forward guidance.

Key Decisions for Investors

• Given the strong bullish analyst consensus and a clear geopolitical catalyst, investors may consider NOC a core holding within the defense sector, targeting the average analyst price of $541.36.
• The upcoming Q2 2025 earnings call on July 22 is a pivotal event; investors should scrutinize management's commentary for evidence that recent geopolitical events are translating into tangible order growth and upward revisions to financial guidance.
• While the outlook is positive, investors should note the stock has already rallied and consider the analyst price target range of $480 to $585, suggesting that a disciplined entry strategy is prudent to manage downside risk from the current price level.